The FDA announced today that a Philips recall involving remote cardiac monitoring software is Class I, its most serious ...
Some electrocardiogram events, such as atrial fibrillation or abnormally rapid heartbeats, over two years were not reviewed ...
The Food and Drug Administration announced that Philips recalled the software following 109 reported injuries and two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results